Edition:
India

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

4.18USD
1:30am IST
Change (% chg)

$0.15 (+3.72%)
Prev Close
$4.03
Open
$4.09
Day's High
$4.22
Day's Low
$4.06
Volume
251,921
Avg. Vol
191,566
52-wk High
$6.96
52-wk Low
$2.08

About

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments... (more)

Overall

Beta: 3.06
Market Cap(Mil.): $186.91
Shares Outstanding(Mil.): 46.38
Dividend: --
Yield (%): --

Financials

UPDATE 1-FDA declines to approve re-launch of ADMA Biologics' Bivigam

Dec 19 The U.S. Food and Drug Administration (FDA)on Wednesday declined to approve ADMA Biologics Inc's application to re-launch its immune deficiency treatment Bivigam, the company said.

20 Dec 2018

FDA declines to approve re-launch of ADMA Biologics' Bivigam

Dec 19 The U.S. Food and Drug Administration on Wednesday declined to approve ADMA Biologics Inc's application to re-launch its immune deficiency treatment Bivigam, the company said.

20 Dec 2018

Earnings vs. Estimates